Retatrutide Dosage Guide for Research Use
RESEARCH REFERENCE · UPDATED 2026
This guide summarizes how retatrutide dosing is typically structured in published research and lab protocols. It is written for laboratory research purposes only — retatrutide is not FDA-approved and none of this is medical or dosing advice for human use.
Why dosage searches for retatrutide are so common
Retatrutide is being studied in clinical trials at specific, controlled dose levels, and a lot of that trial data is publicly discussed. That’s led to a huge amount of search interest in “retatrutide dosage” from people trying to understand the compound — but there’s an important distinction between clinical trial protocols run under medical supervision and anything relevant to unsupervised use, which we’re not going to describe here.
How reconstitution is typically handled in lab settings
Retatrutide is supplied as a lyophilized (freeze-dried) powder and is reconstituted with bacteriostatic water before use in a research setting. Standard peptide reconstitution practice, as followed in laboratory protocols generally, includes:
- Allowing the vial to reach room temperature before adding diluent
- Injecting bacteriostatic water slowly, down the side of the vial rather than directly onto the powder
- Gently swirling — never shaking — to avoid degrading the peptide structure
- Storing the reconstituted solution refrigerated and using it within the timeframe indicated by the supplier’s guidance
Concentration and measurement in research protocols
Because retatrutide trial dosing spans a wide range depending on the study phase and objective, researchers typically calculate concentration (mg/mL) based on the specific vial size and diluent volume used in their protocol, then use a calibrated syringe appropriate for that concentration. Precision here is a data-integrity issue as much as anything else — inconsistent measurement is one of the most common sources of unreliable results in peptide research.
Batch consistency matters more than the number on the label
A dosage figure is only meaningful if the actual peptide content of the vial matches what the label claims. This is why a batch-specific, independently verified Certificate of Analysis matters as much as the dosing protocol itself — see our buyer’s guide for what to check before sourcing a batch, and our COA library for current lab results.
Storage between uses
Both the unreconstituted lyophilized powder and the reconstituted solution have specific storage requirements that affect stability over time. We cover this in full in our storage and handling guide.
Where this guide stops
We’re deliberately not publishing a specific mg-per-week dosing schedule here. Retatrutide dosing in clinical trials is administered under medical supervision at levels determined by trial protocols, and translating that into a generic recommendation for unsupervised use would be irresponsible and outside what we’re able to speak to. If you’re conducting laboratory research, follow your institution’s protocols and consult the primary trial literature directly.
Source a lab-verified batch with COA included
Related guides
- Where to buy retatrutide: complete buyer’s guide
- Storage and handling: do’s and don’ts
- Frequently asked questions
This article is for research and informational purposes only and does not constitute medical or dosing advice. Retatrutide is not approved by the FDA for human use and is sold strictly for laboratory research by qualified individuals.